Oct 15 2009
Pluristem Therapeutics Inc. (NasdaqCM:PSTI)(DAX:PJT) today announced that it will present at the New England-Israel Life Sciences Summit at the Brandeis International Business School in Waltham, Mass. Zami Aberman, chairman and CEO of Pluristem will present an update on the company and an overview of its technology at 9:40 EDT, Oct 27, 2009.
“Selecting Pluristem to present at this conference is a recognition of our innovative technology and its potential to treat several severe ischemic and autoimmune disorders,” said Mr. Aberman. “Our ongoing clinical trials in the U.S. and Europe in patients with critical limb ischemia combined with our proprietary technology, position Pluristem as one of the leading companies in the cell therapy field, not only in Israel but also globally.”
The New England-Israel Life Sciences Summit will feature 15 Israeli life sciences companies that offer cutting edge technologies in the pharmaceuticals, biotechnology, medical devices and healthcare IT industries. The keynote speaker at the summit will be Mr. Israel Makov, Chairman, Given Imaging and former CEO of Teva Pharmaceutical Industries Ltd. Mr. Deval Patrick, the Honorable Governor of Massachusetts, will be the featured speaker.
http://www.pluristem.com/
Human midbrain organoids: A promising tool in the fight against Parkinson's disease